Delivering Value To Those We Serve

News Releases

  • November 6, 1998 at 12:00 AM EST
    FOSTER CITY, CALIF., - November 6, 1998 .. DepoMed, Inc. (Nasdaq: DPMD) announced that its common stock and warrants (Nasdaq: DPMDW) have been approved for listing on the American Stock Exchange under the symbols "DMI" and "DMIW," respectively. The Company expects trading to begin on Monday,
  • November 2, 1998 at 12:00 AM EST
    FOSTER CITY, CALIF., - November 2, 1998 ..... DepoMed, Inc. (Nasdaq: DPMD) announced today revenues of $217,687 for the quarter ended September 30, 1998 compared to $104,454 for the quarter ended September 30, 1997. The Company reported a net loss of $645,496, or $0.10 per share, for the quarter
  • August 5, 1998 at 12:00 AM EDT
    FOSTER CITY, CALIF., - August 5, 1998 ..... DepoMed, Inc. (Nasdaq: DPMD) announced today revenues of $130,000 for the quarter ended June 30, 1998 compared to $225,000 for the quarter ended June 30, 1997. The Company reported a loss of $586,000, or $0.09 per share, for the quarter ended June 30,
  • May 15, 1998 at 12:00 AM EDT
    FOSTER CITY, CALIF., - May 15, 1998 ..... DepoMed, Inc. (Nasdaq: DPMD) announced today revenues of $110,000 for the quarter ended March 31, 1998 compared to $127,000 for the quarter ended March 31, 1997. The Company reported a loss of $493,000, or $0.08 per share, for the quarter ended March 31,
  • March 19, 1998 at 12:00 AM EST
    FOSTER CITY, CA - March 19, 1998 - DepoMed, Inc. (Nasdaq: DPMD) reported revenues of $605,000 for the year ended December 31, 1997, resulting from research and development payments in connection with its ongoing development work with Bristol-Myers Squibb. Revenues were $318,000 in 1996.
  • March 4, 1998 at 12:00 AM EST
    FOSTER CITY, CA - March 4, 1998 - DepoMed, Inc. (Nasdaq: DPMD) announced that it has entered into a research collaboration with the R. W. Johnson Pharmaceutical Research Institute (PRI), a Johnson & Johnson unit, to study the feasibility of an orally administered, controlled release pharmaceutical
  • February 24, 1998 at 12:00 AM EST
    FOSTER CITY, CA - February 24, 1998 - DepoMed, Inc. (Nasdaq: DPMD) announced that it has completed a private placement of common stock for $8 million, with net proceeds of approximately $7.5 million to the Company. Investors agreed to a lock-up provision until November 6th, 1998, the one-year
  • February 12, 1998 at 12:00 AM EST
    FOSTER CITY, CA - February 12, 1998 - DepoMed, Inc. today announced that Dr. W. Leigh Thompson was elected to the Board of Directors on January 30, 1998. Dr. Thompson (59) was previously Chief Scientific Officer at Eli Lilly before founding Profound Quality Resources, Ltd., a private healthcare
  • December 1, 1997 at 12:00 AM EST
    FOSTER CITY, CA - December 1, 1997 - DepoMed, Inc. (Nasdaq: DPMDU) today announced that, effective December 1, 1997, the Common Stock and Warrants comprising the Company's Units will become detachable and separately transferable. Also effective as of December 1, 1997, the shares of Common Stock and
  • November 5, 1997 at 12:00 AM EST
    FOSTER CITY, CA - November 5, 1997 -- DepoMed, Inc. today announced its initial public offering of 1,200,000 Units (each Unit consisting of one share of common stock and one common stock purchase warrant), at a price of $6.10 per Unit. The Units are quoted on the Nasdaq Small Cap Market under the